|Bid||208.26 x 1200|
|Ask||208.41 x 800|
|Day's Range||204.43 - 208.57|
|52 Week Range||154.37 - 211.70|
|Beta (5Y Monthly)||0.77|
|PE Ratio (TTM)||31.99|
|Earnings Date||Jan. 31, 2022 - Feb. 04, 2022|
|Forward Dividend & Yield||4.48 (2.19%)|
|Ex-Dividend Date||Sep. 29, 2021|
|1y Target Est||225.95|
While the COVID-19 pandemic has been difficult for office real estate investment trusts (REITs), some have performed better than others. Companies in the life sciences space have benefited from increased government spending on research and development. The most prominent life sciences office REIT is Alexandria Real Estate Equities (NYSE: ARE).
For tax reasons, REITs are required to pay out at least 90% of their taxable income as dividends, and because of these investment vehicles tend to concentrate in specific industry segments, they can be solid picks for capital appreciation, too. Today, we are going to take a look at two REITs that have this potential. Alexandria Real Estate Equities is an office REIT, and one of the larger ones, but even in this specialized sector, it's not like all the others.
ARE earnings call for the period ending September 30, 2021.